Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-802-8 | CAS number: 68608-82-2 A complex combination of hydrocarbons obtained by the alkylation of benzene with ethene. It consists primarily of ethylbiphenyls, diethylbenzenes with lesser amounts of butylbenzenes and polyethylbenzenes.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Mutagenicity in bacteria:
Monsanto (1985), ACC (2005) and Dow (1987) Ames assays are available with the UVCB substance. Overall, this substance was tested in 5 Salmonella strains (TA1535, TA1537, TA1538, TA100, TA98) and in the E.coli WP2 uvrA strain with and without metabolic activation. In one out of three Ames assays with TA100 strain, the ACC substance produced a weakly positive response with metabolic activation in some, but not all, assay trials and the response was without a clear concentration- related increase across tested doses. This equivocal response in TA100 was not reproduced in the other two Ames assays in TA100 strain with this UVCB substance. All other bacterial strains tested with the registered UVCB substance did not produce a positive response. Overall, it can be concluded that the UVCB substance 'benzene, ethylenated by- products from' does not present mutagenic activity in bacteria. Together with the results of testing in mammalian cells, the weight of evidence indicates that this substance has no mutagenic potential in vitro.
Chromosome aberration in vitro:
Monsanto (1987), ACC (2006) and two Dow (1987) Chromosome Aberration assays in CHO cells are available with the UVCB substance. No biologically significant increases in structural or numerical aberrations were observed in chromosomes at any dose levels in any exposure regimen with and without metabolic activation. Therefore in all 4 assays, the UVCB substance 'benzene, ethylenated by- products from' was not clastogenic to mammalian cells in culture.
Mammalian gene mutation assay in vitro:
Monsanto (1986) HGPRT gene mutation assay in CHO cells is available with the UVCB substance. In the study, no statistically significant increases in mutant frequency were observed with the test substance with and without metabolic activation. Therefore, this outcome supports the spurious Ames results in one out of three assays with the TA100 strain that reverts by base pair substitution at GC base pair as non reproducible and of low relevance to the general conclusions for this substance. Overall, the weight of evidence indicates that 'benzene, ethylenated by- products from' has no mutagenic potential in vitro.
Unscheduled DNA synthesis:
Monsanto (1986) and three Dow (1987) unscheduled DNA synthesis (UDS) assays in primary rat hepatocyte cultures are available with the UVCB substance. Induction of DNA repair (via increased DNA synthesis) as a result of treatment with various UVCB 'benzene, ethylenated by- products from' substances was not observed in any of the four assays. Therefore, the UVCB substances did not produce any evidence of genotoxicity.
Together, the available in vitro genetic toxicology data indicate that this substance does not possess mutagenic potential in bacteria or mammalian cells, does not induce DNA repair activity, nor does it possess the ability to cause chromosome aberrations. Overall, the weight of evidence indicates that 'benzene, ethylenated by- products from' has no genotoxic potential in vitro. Thus, no in vivo follow up is proposed for 'benzene, ethylenated by- products from' substance.
Short description of key information:
3 Ames assays on the UVCB REACH substance
4 unscheduled DNA synthesis assays
3 Chromosomal Aberration assays and an in vitro cytogenetics assay
1 Mammalian mutagenicity assay (CHO/HGPRT)
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
As the available genetic toxicity data demonstrate that the UVCB 'benzene, ethylenated by- products from' substance is not mutagenic or genotoxic in vitro, no classification for this endpoint is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.